Half-Year 2022 Financial and Clinical Trials Update

HY 2022: Diagnostics Division regional sales Very strong growth in Asia Pacific and North America Roche North America +34% ~29% of divisional sales EMEA1 -14% ~33% of divisional sales Latin America +2% ~6% of divisional sales Asia Pacific +39% ~32% of divisional sales Growth rates at CER (Constant exchange Rates); 1 Europe, Middle East and Africa 36 56

View entire presentation